BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22217870)

  • 1. Amides of xanthurenic acid as zinc-dependent inhibitors of Lp-PLA(2).
    Lin EC; Hu Y; Amantea CM; Pham LM; Cajica J; Okerberg E; Brown HE; Fraser A; Du L; Kohno Y; Ishiyama J; Kozarich JW; Shreder KR
    Bioorg Med Chem Lett; 2012 Jan; 22(2):868-71. PubMed ID: 22217870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amides of 4-hydroxy-8-methanesulfonylamino-quinoline-2-carboxylic acid as zinc-dependent inhibitors of Lp-PLA₂.
    Hu Y; Lin EC; Pham LM; Cajica J; Amantea CM; Okerberg E; Brown HE; Fraser A; Du L; Kohno Y; Ishiyama J; Kozarich JW; Shreder KR
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1553-6. PubMed ID: 23333209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triazole derivatives: a series of Darapladib analogues as orally active Lp-PLA2 inhibitors.
    Wang K; Xu W; Zhang W; Mo M; Wang Y; Shen J
    Bioorg Med Chem Lett; 2013 May; 23(10):2897-901. PubMed ID: 23575276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model.
    Attenni B; Ontoria JM; Cruz JC; Rowley M; Schultz-Fademrecht C; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3081-4. PubMed ID: 19410459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.
    Shinji C; Maeda S; Imai K; Yoshida M; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2006 Nov; 14(22):7625-51. PubMed ID: 16877001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structures, and urease inhibitory activities of three copper(II) and zinc(II) complexes with 2-{[2-(2-hydroxyethylamino)ethylimino]methyl}-4-nitrophenol.
    You ZL; Ni LL; Shi DH; Bai S
    Eur J Med Chem; 2010 Jul; 45(7):3196-9. PubMed ID: 20362357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group.
    Tanaka A; Radwan MO; Hamasaki A; Ejima A; Obata E; Koga R; Tateishi H; Okamoto Y; Fujita M; Nakao M; Umezawa K; Tamanoi F; Otsuka M
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3862-3866. PubMed ID: 28666734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
    Song JX; Ren JY; Chen H
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2.
    Ashton KS; St Jean DJ; Poon SF; Lee MR; Allen JG; Zhang S; Lofgren JA; Zhang X; Fotsch C; Hungate R
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5191-6. PubMed ID: 21824779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile preparation of allylzinc species from allylboronates and zinc amide via a boron-to-zinc exchange process and their reactions with carbonyl compounds, imines and hydrazones.
    Cui Y; Yamashita Y; Kobayashi S
    Chem Commun (Camb); 2012 Oct; 48(83):10319-21. PubMed ID: 22984692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of GHTD-amide and analogs to enhance insulin activity through zinc chelation and dispersal of insulin oligomers.
    Paule SG; Nikolovski B; Ludeman J; Gray RE; Spiccia L; Zimmet PZ; Myers MA
    Peptides; 2009 Jun; 30(6):1088-97. PubMed ID: 19463741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of new mono- and heptazinc complexes with unusual amide coordination modes.
    Bera M; Musie GT; Powell DR
    Inorg Chem; 2009 Jun; 48(11):4625-7. PubMed ID: 19391597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Discovered through X-ray Fragment Screening.
    Woolford AJ; Pero JE; Aravapalli S; Berdini V; Coyle JE; Day PJ; Dodson AM; Grondin P; Holding FP; Lee LY; Li P; Manas ES; Marino J; Martin AC; McCleland BW; McMenamin RL; Murray CW; Neipp CE; Page LW; Patel VK; Potvain F; Rich S; Rivero RA; Smith K; Somers DO; Trottet L; Velagaleti R; Williams G; Xie R
    J Med Chem; 2016 Jun; 59(11):5356-67. PubMed ID: 27167608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of an organometallic glutathione transferase inhibitor.
    Ang WH; Parker LJ; De Luca A; Juillerat-Jeanneret L; Morton CJ; Lo Bello M; Parker MW; Dyson PJ
    Angew Chem Int Ed Engl; 2009; 48(21):3854-7. PubMed ID: 19396894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors.
    Nepali K; Agarwal A; Sapra S; Mittal V; Kumar R; Banerjee UC; Gupta MK; Satti NK; Suri OP; Dhar KL
    Bioorg Med Chem; 2011 Sep; 19(18):5569-76. PubMed ID: 21862335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
    Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
    J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tris[(R)-lactamide-kappa2O,O']zinc(II) tetrabromozincate.
    Bekaert A; Lemoine P; Brion JD; Viossat B
    Acta Crystallogr C; 2005 Feb; 61(Pt 2):m76-7. PubMed ID: 15695896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A(2).
    Nagano JM; Hsu KL; Whitby LR; Niphakis MJ; Speers AE; Brown SJ; Spicer T; Fernandez-Vega V; Ferguson J; Hodder P; Srinivasan P; Gonzalez TD; Rosen H; Bahnson BJ; Cravatt BF
    Bioorg Med Chem Lett; 2013 Feb; 23(3):839-43. PubMed ID: 23260346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship for aryl and heteroaryl boronic acid inhibitors of hormone-sensitive lipase.
    Ebdrup S; Jacobsen P; Farrington AD; Vedsø P
    Bioorg Med Chem; 2005 Mar; 13(6):2305-12. PubMed ID: 15727879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.
    Maingot L; Elbakali J; Dumont J; Bosc D; Cousaert N; Urban A; Deglane G; Villoutreix B; Nagase H; Sperandio O; Leroux F; Deprez B; Deprez-Poulain R
    Eur J Med Chem; 2013 Nov; 69():244-61. PubMed ID: 24044937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.